Terkko Navigator / Eerikkoi/ Feeds

Qualitative Findings on the Impact of Disease in Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Patients, as Measured by EQ-5D, SF-36, and the FACT-LYM

Living with Advanced Hormone-Sensitive Prostate Cancer and Treatment with Abiraterone and Androgen Deprivation Therapy: The Patient, Nursing and Physician Perspective

Analyzing Controversies in Management and Surveillance of Early-Stage Melanoma

An Overview of Current Recommendations and Options for the Management of Cancer Pain: A Comprehensive Review

Pulmonary Fibrosis Secondary to Oxaliplatin Treatment: From Rarity to Reality: A Case Study and Literature Review

Response to Abemaciclib After 10 Lines of Therapy Including Palbociclib in Metastatic Breast Cancer: A Case Report With Literature Review

Information Needs of Black Prostate Cancer Patients Receiving Treatment Within the South African Public Healthcare System

Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months

Real-World Impact of Physician and Patient Discordance on Health-Related Quality of Life in US Patients with Acute Myeloid Leukemia

Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia

Correction to: Uveal Melanoma: A Review of the Literature

Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke

The Roles of Common Variation and Somatic Mutation in Cancer Pharmacogenomics

Review of the Agnostic-Type Treatment Approach: Treating Cancer by Mutations, Not by Location

Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma

Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study

Genetic Pathway in the Pathogenesis of Therapy-Related Myeloid Neoplasms: A Literature Review

Characteristics of Laryngeal Osteosarcoma: A Critical Review

Gender Differences and Outcomes in Melanoma Patients

The Time Has Come for Targeted Therapies for AML: Lights and Shadows

Carcinoma In Situ Involving Sclerosing Adenosis on Core Biopsy: Diagnostic Pearls to Aid the Practicing Clinician and Avoid Overtreatment

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review

Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Patient Survey of the Physical, Emotional, and Informational Challenges for Patients Living with Neuroendocrine Tumors

⁶⁴Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors

A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach

The Potential Use of Tumour-Based Prognostic and Predictive Tools in Older Women with Primary Breast Cancer: A Narrative Review

Is There a Role for Multiple Lines of Anti-HER2 Therapies Administered Beyond Progression in HER2-Mutated Non-Small Cell Lung Cancer? A Case Report and Literature Review

Integration of Physician and Nursing Professional Efforts to Deliver Supportive Scalp Cooling Care to Oncology Patients at Risk for Alopecia

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting

Value Added Impact of Both Point-of-Care and Laboratory Lactic Acid Analysis When Emergently Evaluating Cancer Patients

Overall Survival Improved for Contemporary Patients with Melanoma: A 2004-2015 National Cancer Database Analysis

RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature

Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis

Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting

Excision of a Large Gastrointestinal Stromal Tumour Following 16 Months of Neoadjuvant Therapy with Imatinib (Case Report)

Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

A Review of Immune-Mediated Adverse Events in Melanoma

Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1

Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases

The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice

Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient-Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study

Mastocytosis: One Word for Different Diseases

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan

The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria

Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation

Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program